Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D
About this episode
This episode discusses the role of health systems in managing chronic kidney disease associated with type 1 and type 2 diabetes.
To achieve optimal outcomes for patients, it is not only the individual efforts of clinicians that matter in achieving optimal outcomes for our patients. Having a system that supports and facilitates those efforts is essential. In this special episode, Neil Skolnik speaks with Nihar Desai about the challenges of managing chronic kidney disease and diabetes. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to DOC Updates via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Nihar Desai , MD, MPH, Associate Professor of Medicine and Associate Chief of the Section of Cardiovascular Medicine at Yale University School of Medicine, Investigator at the Center for Outcomes Research and Evaluation, and Medical Director for Value Innovation at the Yale New Haven Health System. Selected references: Chronic Kidney Disease and Risk Management…
People in this episode
Host: Neil Skolnik
Guest: Nihar Desai
Topics covered
- chronic kidney disease
- type 1 diabetes
- type 2 diabetes
- health systems
- patient outcomes
- clinical management
Keywords
- chronic kidney disease
- type 1 diabetes
- type 2 diabetes
- health systems
- patient outcomes
- clinical management
- Neil Skolnik
- Nihar Desai
- Bayer
- American Diabetes Association
Sponsors
Bayer
Mentioned in this episode
Organizations: American Diabetes Association
Books & works: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026, Finerenone in Type 1 Diabetes and Chronic Kidney Disease, Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
More episodes of DOC Updates
- Special Edition: Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone
- Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance
- Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!
- Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!
- Special Edition: Hypertension Part I—Overview and Management
Explore listener stats, chart rankings, contacts and more on the DOC Updates podcast page.